Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bellone

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Acta Diabetologica Latina|July 1, 1989
Impairment of lymphocyte suppressive system in recent onset insulin-dependent diabetes mellitus. Correlation with blood glucose and serum insulin levelsA Secchi, F Crosti, L Bonisolli, et al.
European Journal of Immunology|August 1, 1996
Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumorsA Martin-Fontecha, F Cavallo, M Bellone, et al.
Cancer Research|March 15, 1996
Particulate naturally processed peptides prime a cytotoxic response against human melanoma in vitroM P Protti, M A Imro, A A Manfredi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokinesA Ronchetti, P Rovere, G Iezzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
Rejection of a nonimmunogenic melanoma by vaccination with natural melanoma peptides on engineered antigen-presenting cellsM Bellone, G Iezzi, A Martin-Fontecha, et al.
The Journal of Experimental Medicine|March 2, 1999
Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11S Manici, T Sturniolo, M A Imro, et al.
Annals of Hematology|November 9, 2002
Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphomaF Folli, L Perego, M Ponzoni, et al.
Cytokine & Growth Factor Reviews|October 15, 2017
Innovative Therapy, Monoclonal Antibodies and BeyondM Di Nicola, L Apetoh, M Bellone, et al.
Oncogene|June 17, 2014
Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancerU Orfanelli, E Jachetti, F Chiacchiera, et al.
British Journal of Cancer|August 12, 2010
hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinomaE Cocco, Z Hu, C E Richter, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Acta Diabetologica Latina|July 1, 1989
Impairment of lymphocyte suppressive system in recent onset insulin-dependent diabetes mellitus. Correlation with blood glucose and serum insulin levelsA Secchi, F Crosti, L Bonisolli, et al.
European Journal of Immunology|August 1, 1996
Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumorsA Martin-Fontecha, F Cavallo, M Bellone, et al.
Cancer Research|March 15, 1996
Particulate naturally processed peptides prime a cytotoxic response against human melanoma in vitroM P Protti, M A Imro, A A Manfredi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokinesA Ronchetti, P Rovere, G Iezzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
Rejection of a nonimmunogenic melanoma by vaccination with natural melanoma peptides on engineered antigen-presenting cellsM Bellone, G Iezzi, A Martin-Fontecha, et al.
The Journal of Experimental Medicine|March 2, 1999
Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11S Manici, T Sturniolo, M A Imro, et al.
Annals of Hematology|November 9, 2002
Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphomaF Folli, L Perego, M Ponzoni, et al.
Cytokine & Growth Factor Reviews|October 15, 2017
Innovative Therapy, Monoclonal Antibodies and BeyondM Di Nicola, L Apetoh, M Bellone, et al.
Oncogene|June 17, 2014
Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancerU Orfanelli, E Jachetti, F Chiacchiera, et al.
British Journal of Cancer|August 12, 2010
hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinomaE Cocco, Z Hu, C E Richter, et al.
Pageof 6